Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2012 (2012), Article ID 650382, 12 pages
http://dx.doi.org/10.1155/2012/650382
Review Article

Disruption of the Serotonergic System after Neonatal Hypoxia-Ischemia in a Rodent Model

1Royal Brisbane and Women’s Hospital, The University of Queensland, Herston, QLD 4029, Australia
2Clinical Neuroscience, Perinatal Research Centre, The University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University of Queensland, Herston, QLD 4029, Australia

Received 7 September 2011; Revised 26 October 2011; Accepted 1 November 2011

Academic Editor: Robin L. Haynes

Copyright © 2012 Kathryn M. Buller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Volpe, “Brain injury in the premature infant: neuropathology, clinical aspects, and pathogenesis,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 3, no. 1, pp. 3–12, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Volpe, “Neurobiology of periventricular leukomalacia in the premature infant,” Pediatric Research, vol. 50, no. 5, pp. 553–562, 2001. View at Google Scholar · View at Scopus
  3. B. Larroque, P. Y. Ancel, S. Marret et al., “Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study,” The Lancet, vol. 371, no. 9615, pp. 813–820, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. B. S. Peterson, A. W. Anderson, R. Ehrenkranz et al., “Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants,” Pediatrics, vol. 111, no. 5, pp. 939–948, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Anderson and L. W. Doyle, “Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s,” Journal of the American Medical Association, vol. 289, no. 24, pp. 3264–3272, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. O'Brien, S. Roth, A. Stewart, L. Rifkin, T. Rushe, and J. Wyatt, “The neurodevelopmental progress of infants less than 33 weeks into adolescence,” Archives of Disease in Childhood, vol. 89, no. 3, pp. 207–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hack, E. A. Youngstrom, L. Cartar et al., “Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years,” Pediatrics, vol. 114, no. 4, pp. 932–940, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. P. Logitharajah, M. A. Rutherford, and F. M. Cowan, “Hypoxic-ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome,” Pediatric Research, vol. 66, no. 2, pp. 222–229, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. D. Selway, “State of the science: hypoxic ischemic encephalopathy and hypothermic intervention for neonates,” Advances in Neonatal Care, vol. 10, no. 2, pp. 60–66, 2010. View at Google Scholar · View at Scopus
  10. R. H. Pfister and R. F. Soll, “Hypothermia for the treatment of infants with hypoxic-ischemic encephalopathy,” Journal of Perinatology, vol. 30, no. 1, pp. S82–S87, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. R. Pierson, R. D. Folkerth, S. S. Billiards et al., “Gray matter injury associated with periventricular leukomalacia in the premature infant,” Acta Neuropathologica, vol. 114, no. 6, pp. 619–631, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. J. Volpe, “Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances,” The Lancet Neurology, vol. 8, no. 1, pp. 110–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Leviton and P. Gressens, “Neuronal damage accompanies perinatal white-matter damage,” Trends in Neurosciences, vol. 30, no. 9, pp. 473–478, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. S. S. Billiards, R. L. Haynes, R. D. Folkerth et al., “Development of microglia in the cerebral white matter of the human fetus and infant,” Journal of Comparative Neurology, vol. 497, no. 2, pp. 199–208, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. L. Haynes, R. D. Folkerth, R. J. Keefe et al., “Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 5, pp. 441–450, 2003. View at Google Scholar · View at Scopus
  16. C. Nosarti, T. M. Rushe, P. W. R. Woodruff, A. L. Stewart, L. Rifkin, and R. M. Murray, “Corpus callosum size and very preterm birth: relationship to neuropsychological outcome,” Brain, vol. 127, no. 9, pp. 2080–2089, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. T. E. Inder, P. S. Huppi, S. Warfield et al., “Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term,” Annals of Neurology, vol. 46, no. 5, pp. 755–760, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Ricci, S. Anker, F. Cowan et al., “Thalamic atrophy in infants with PVL and cerebral visual impairment,” Early Human Development, vol. 82, no. 9, pp. 591–595, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. B. S. Peterson, B. Vohr, L. H. Staib et al., “Regional brain volume abnormalities and long-term cognitive outcome in preterm infants,” Journal of the American Medical Association, vol. 284, no. 15, pp. 1939–1947, 2000. View at Google Scholar · View at Scopus
  20. S. R. Kesler, L. R. Ment, B. Vohr et al., “Volumetric analysis of regional cerebral development in preterm children,” Pediatric Neurology, vol. 31, no. 5, pp. 318–325, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. L. Zubiaurre-Elorza, S. Soria-Pastor, C. Junque et al., “Gray matter volume decrements in preterm children with periventricular leukomalacia,” Pediatric Research, vol. 69, no. 6, pp. 554–560, 2011. View at Publisher · View at Google Scholar · View at PubMed
  22. R. L. Haynes, S. S. Billiards, N. S. Borenstein, J. J. Volpe, and H. C. Kinney, “Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin,” Pediatric Research, vol. 63, no. 6, pp. 656–661, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. A. Larouche, M. Roy, H. Kadhim, A. M. Tsanaclis, D. Fortin, and G. Sébire, “Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy,” Developmental Neuroscience, vol. 27, no. 2–4, pp. 134–142, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. Marín-Padilla, “Developmental neuropathology and impact of perinatal brain damage. III: gray matter lesions of the neocortex,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 5, pp. 407–429, 1999. View at Google Scholar
  25. W. Nakajima, A. Ishida, M. S. Lange et al., “Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat,” Journal of Neuroscience, vol. 20, no. 21, pp. 7994–8004, 2000. View at Google Scholar · View at Scopus
  26. F. J. Northington, D. M. Ferriero, D. L. Flock, and L. J. Martin, “Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis,” Journal of Neuroscience, vol. 21, no. 6, pp. 1931–1938, 2001. View at Google Scholar · View at Scopus
  27. T. F. Oo, C. Henchcliffe, and R. E. Burke, “Apoptosis in substantia nigra following developmental hypoxic-ischemic injury,” Neuroscience, vol. 69, no. 3, pp. 893–901, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. K. M. Buller, J. A. Wixey, P. Pathipati et al., “Selective losses of brainstem catecholamine neurons after hypoxia-ischemia in the immature rat pup,” Pediatric Research, vol. 63, no. 4, pp. 364–369, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. C. F. Loidl, M. Herrera-Marschitz, K. Andersson et al., “Long-term effects of perinatal asphyxia on basal ganglia neurotransmitter systems studied with microdialysis in rat,” Neuroscience Letters, vol. 175, no. 1-2, pp. 9–12, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. M. V. Johnston and C. Hudson, “Effects of postnatal hypoxia-ischemia on cholinergic neurons in the developing rat forebrain: choline acetyltransferase immunocytochemistry,” Brain Research, vol. 431, no. 1, pp. 41–50, 1987. View at Google Scholar · View at Scopus
  31. G. V. Allen, R. T. F. Cheung, and D. F. Cechetto, “Neurochemical changes following occlusion of the middle cerebral artery in rats,” Neuroscience, vol. 68, no. 4, pp. 1037–1050, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Kohlhauser, S. Kaehler, W. Mosgoeller et al., “Histological changes and neurotransmitter levels three months following perinatal asphyxia in the rat,” Life Sciences, vol. 64, no. 23, pp. 2109–2124, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Herlenius and H. Lagercrantz, “Development of neurotransmitter systems during critical periods,” Experimental Neurology, vol. 190, no. 1, pp. S8–S21, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. C. Currás-Collazo, U. B. Patel, and M. O. Hussein, “Reduced susceptibility of magnocellular neuroendocrine nuclei of the rat hypothalamus to transient focal ischemia produced by middle cerebral artery occlusion,” Experimental Neurology, vol. 178, no. 2, pp. 268–279, 2002. View at Publisher · View at Google Scholar
  35. J. Gross, I. Müller, Y. Chen et al., “Perinatal asphyxia induces region-specific long-term changes in mRNA levels of tyrosine hydroxylase and dopamine D1 and D2 receptors in rat brain,” Molecular Brain Research, vol. 79, no. 1-2, pp. 110–117, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. R. T. F. Cheung and D. F. Cechetto, “Colchicine affects cortical and amygdalar neurochemical changes differentially after middle cerebral artery occlusion in rats,” Journal of Comparative Neurology, vol. 387, no. 1, pp. 27–41, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Gaspar, O. Cases, and L. Maroteaux, “The developmental role of serotonin: news from mouse molecular genetics,” Nature Reviews Neuroscience, vol. 4, no. 12, pp. 1002–1012, 2003. View at Google Scholar · View at Scopus
  38. S. E. Gartside, D. A. Johnson, M. M. Leitch, C. Troakes, and C. D. Ingram, “Early life adversity programs changes in central 5-HT neuronal function in adulthood,” European Journal of Neuroscience, vol. 17, no. 11, pp. 2401–2408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. K. L. Gardner, K. V. Thrivikraman, S. L. Lightman, P. M. Plotsky, and C. A. Lowry, “Early life experience alters behavior during social defeat: focus on serotonergic systems,” Neuroscience, vol. 136, no. 1, pp. 181–191, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. C. A. Lowry, P. L. Johnson, A. Hay-Schmidt, J. Mikkelsen, and A. Shekhar, “Modulation of anxiety circuits by serotonergic systems,” Stress, vol. 8, no. 4, pp. 233–246, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. J. R. Duncan, D. S. Paterson, J. M. Hoffman et al., “Brainstem serotonergic deficiency in sudden infant death syndrome,” Journal of the American Medical Association, vol. 303, no. 5, pp. 430–437, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. C. B. Nemeroff and M. J. Owens, “The role of serotonin in the pathophysiology of depression: as important as ever,” Clinical Chemistry, vol. 55, no. 8, pp. 1578–1579, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. C. A. Pardo and C. G. Eberhart, “The neurobiology of autism,” Brain Pathology, vol. 17, no. 4, pp. 434–447, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. D. M. Ferriero, “Neonatal brain injury,” The New England Journal of Medicine, vol. 351, pp. 1985–1995, 2004. View at Google Scholar
  45. B. Baumann, H. Bielau, D. Krell et al., “Circumscribed numerical deficit of dorsal raphe neurons in mood disorders,” Psychological Medicine, vol. 32, no. 1, pp. 93–103, 2002. View at Google Scholar · View at Scopus
  46. L. A. Rone and S. J. Ferrando, “Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy,” Psychosomatics, vol. 37, no. 2, pp. 165–166, 1996. View at Google Scholar · View at Scopus
  47. G. Krakovsky, M. M. Huth, L. Lin, and R. S. Levin, “Functional changes in children, adolescents, and young adults with cerebral palsy,” Research in Developmental Disabilities, vol. 28, no. 4, pp. 331–340, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. H. Hagberg, D. Peebles, and C. Mallard, “Models of white matter injury: comparison of infectious, hypoxic-Ischemic, and excitotoxic insults,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 8, no. 1, pp. 30–38, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. S. A. Back, N. L. Luo, N. S. Borenstein, J. M. Levine, J. J. Volpe, and H. C. Kinney, “Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury,” Journal of Neuroscience, vol. 21, no. 4, pp. 1302–1312, 2001. View at Google Scholar · View at Scopus
  50. M. L. Carty, J. A. Wixey, P. B. Colditz, and K. M. Buller, “Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens,” International Journal of Developmental Neuroscience, vol. 26, no. 5, pp. 477–485, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. S. V. Sizonenko, J. Z. Kiss, T. Inder, P. D. Gluckman, and C. E. Williams, “Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain,” Pediatric Research, vol. 57, no. 6, pp. 865–872, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. D. J. Walther, J. U. Peter, S. Bashammakh et al., “Synthesis of serotonin by a second tryptophan hydroxylase isoform,” Science, vol. 299, no. 5603, p. 76, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. R. D. Blakely, H. E. Berson, R. T. Fremeau et al., “Cloning and expression of a functional serotonin transporter from rat brain,” Nature, vol. 353, no. 6348, pp. 66–70, 1991. View at Google Scholar · View at Scopus
  54. A. Dahlström and K. Fuxe, “Localization of monoamines in the lower brain stem,” Experientia, vol. 20, no. 7, pp. 398–399, 1964. View at Publisher · View at Google Scholar · View at Scopus
  55. J. P. Hornung, “The human raphe nuclei and the serotonergic system,” Journal of Chemical Neuroanatomy, vol. 26, no. 4, pp. 331–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. H. C. Kinney, K. G. Broadbelt, R. L. Haynes, I. J. Rognum, and D. S. Paterson, “The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasis,” Journal of Chemical Neuroanatomy, vol. 41, no. 4, pp. 182–199, 2011. View at Publisher · View at Google Scholar · View at PubMed
  57. M. Hayashi, M. Itoh, S. Araki et al., “Immunohistochemical analysis of brainstem lesions in infantile spasms,” Neuropathology, vol. 20, no. 4, pp. 297–303, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. H. E. Reinebrant, J. A. Wixey, G. C. Gobe, P. B. Colditz, and K. M. Buller, “Differential effects of neonatal hypoxic-ischemic brain injury on brainstem serotonergic raphe nuclei,” Brain Research, vol. 1322, pp. 124–133, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. Y. Takeuchi, K. Fujiwara, K. Ishimura et al., “Effects of neonatal asphyxlia on the serotonin neuron system in the developing brain studied by immunohistochemistry,” Developmental Neuroscience, vol. 14, no. 5-6, pp. 394–402, 1992. View at Google Scholar · View at Scopus
  60. M. Shiraishi, Y. Takizawa, S. Ide, T. Obonai, Y. I. Goto, and M. Itoh, “Brainstem monoamine pathology of neonatal hypoxic-ischemic brain damage: a model of acute stage of neonatal asphyxia,” Brain Research, vol. 1213, pp. 120–126, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. B. E. Kosofsky and M. E. Molliver, “The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei,” Synapse, vol. 1, no. 2, pp. 153–168, 1987. View at Google Scholar · View at Scopus
  62. K. A. Michelsen, C. Schmitz, and H. W. M. Steinbusch, “The dorsal raphe nucleus-from silver stainings to a role in depression,” Brain Research Reviews, vol. 55, no. 2, pp. 329–342, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. R. M. Bowker, K. N. Westlund, and J. D. Coulter, “Origins of serotonergic projections to the spinal cord in rat: an immunocytochemical-retrograde transport study,” Brain Research, vol. 226, no. 1-2, pp. 187–199, 1981. View at Google Scholar · View at Scopus
  64. R. R. Clancy, J. T. Stadky, and L. B. Rorke, “Hypoxic-ischemic spinal cord injury following perinatal asphyxia,” Annals of Neurology, vol. 25, no. 2, pp. 185–189, 1989. View at Google Scholar · View at Scopus
  65. F. Groenendaal, J. Vles, H. Lammers, J. De Vente, D. Smit, and P. G. J. Nikkels, “Nitrotyrosine in human neonatal spinal cord after perinatal asphyxia,” Neonatology, vol. 93, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. M. Hadjiconstantinou, A. J. Yates, and N. H. Neff, “Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside,” Journal of Neurochemistry, vol. 55, no. 3, pp. 864–869, 1990. View at Publisher · View at Google Scholar · View at Scopus
  67. J. A. Wixey, H. E. Reinebrant, and K. M. Buller, “Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain,” Journal of Neuropathology and Experimental Neurology, vol. 70, no. 1, pp. 23–35, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. J. A. Wixey, H. E. Reinebrant, S. J. Spencer, and K. M. Buller, “Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia-induced damage to the serotonergic system in the immature rat brain,” Neuroscience, vol. 182, pp. 184–192, 2011. View at Publisher · View at Google Scholar · View at PubMed
  69. F. C. Zhou, J. H. Tao-Cheng, L. Segu, T. Patel, and Y. Wang, “Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence,” Brain Research, vol. 805, no. 1-2, pp. 241–254, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. H. R. Smith and L. J. Porrino, “The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala,” Brain Structure and Function, vol. 213, no. 1-2, pp. 73–91, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. H. Yamamoto, M. Fujimiya, Y. Shirai, M. Nakashita, M. Oyasu, and N. Saito, “Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain,” Neuroscience Research, vol. 32, no. 4, pp. 305–312, 1998. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Qian, H. E. Melikian, D. B. Rye, A. I. Levey, and R. D. Blakely, “Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies,” Journal of Neuroscience, vol. 15, no. 2, pp. 1261–1274, 1995. View at Google Scholar · View at Scopus
  73. D. L. Murphy, M. A. Fox, K. R. Timpano et al., “How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems,” Neuropharmacology, vol. 55, no. 6, pp. 932–960, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. V. Dave, K. J. Mullaney, S. Goderie, H. K. Kimelberg, and M. Aschner, “Astrocytes as mediators of methylmercury neurotoxicity: effects on D-aspartate and serotonin uptake,” Developmental Neuroscience, vol. 16, no. 3-4, pp. 222–231, 1994. View at Google Scholar · View at Scopus
  75. N. Bel, G. Figueras, M. T. Vilaró, C. Suñol, and F. Artigas, “Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain,” European Journal of Neuroscience, vol. 9, no. 8, pp. 1728–1738, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Kubota, Y. Kiuchi, M. Nemoto et al., “Regulation of serotonin transporter gene expression in human glial cells by growth factors,” European Journal of Pharmacology, vol. 417, no. 1-2, pp. 69–76, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Inazu, H. Takeda, H. Ikoshi, M. Sugisawa, Y. Uchida, and T. Matsumiya, “Pharmacological characterization and visualization of the glial serotonin transporter,” Neurochemistry International, vol. 39, no. 1, pp. 39–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Horikawa, T. A. Kato, Y. Mizoguchi et al., “Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 7, pp. 1306–1316, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. R. C. Vannucci, D. T. Lyons, and F. Vasta, “Regional cerebral blood flow during hypoxia-ischemia in immature rats,” Stroke, vol. 19, no. 2, pp. 245–250, 1988. View at Google Scholar · View at Scopus
  80. D. W. Choi, “Excitotoxicity, apoptosis, and ischemic stroke,” Journal of Biochemistry and Molecular Biology, vol. 34, no. 1, pp. 8–14, 2001. View at Google Scholar · View at Scopus
  81. J. L. Wayenberg, V. Ransy, D. Vermeylen, E. Damis, and S. P. Bottari, “Nitrated plasma albumin as a marker of nitrative stress and neonatal encephalopathy in perinatal asphyxia,” Free Radical Biology and Medicine, vol. 47, no. 7, pp. 975–982, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. G. Buonocore and F. Groenendaal, “Anti-oxidant strategies,” Seminars in Fetal and Neonatal Medicine, vol. 12, no. 4, pp. 287–295, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. K. L. Arvin, B. H. Han, Y. Du, S. Z. Lin, S. M. Paul, and D. M. Holtzman, “Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury,” Annals of Neurology, vol. 52, no. 1, pp. 54–61, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. Z. Cai, S. Lin, L. W. Fan, Y. Pang, and P. G. Rhodes, “Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain,” Neuroscience, vol. 137, no. 2, pp. 425–435, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. S. G. Kremlev, R. L. Roberts, and C. Palmer, “Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain,” Journal of Neuroscience Research, vol. 85, no. 11, pp. 2450–2459, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. P. Toti, C. De Felice, K. Schürfeld et al., “Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain: an autopsy study,” Journal of Submicroscopic Cytology and Pathology, vol. 33, no. 3, pp. 245–249, 2001. View at Google Scholar
  87. W. Yin, A. P. Signore, M. Iwai et al., “Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation,” Stroke, vol. 38, no. 3, pp. 1017–1024, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. D. Šumanović-Glamuzina, F. Čulo, M.-I. Čulo et al., “Vasodilatory prostaglandins in perinatal hypoxic brain damage,” Collegium Antropologicum, vol. 32, pp. 183–187, 2008. View at Google Scholar
  89. E. Bona, A. L. Andersson, K. Blomgren et al., “Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats,” Pediatric Research, vol. 45, no. 4, pp. 500–509, 1999. View at Google Scholar · View at Scopus
  90. S. Girard, G. Sébire, and H. Kadhim, “Proinflammatory orientation of the interleukin 1 system and downstream induction of matrix metalloproteinase 9 in the pathophysiology of human perinatal white matter damage,” Journal of Neuropathology and Experimental Neurology, vol. 69, no. 11, pp. 1116–1129, 2010. View at Publisher · View at Google Scholar · View at PubMed
  91. H. Kadhim, B. Tabarki, G. Verellen, C. De Prez, A. M. Rona, and G. Sébire, “Inflammatory cytokines in the pathogenesis of periventricular leukomalacia,” Neurology, vol. 56, no. 10, pp. 1278–1284, 2001. View at Google Scholar · View at Scopus
  92. J. M. Vela, E. Molina-Holgado, Á. Arévalo-Martín, G. Almazán, and C. Guaza, “Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells,” Molecular and Cellular Neuroscience, vol. 20, no. 3, pp. 489–502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Dringen, R. Gebhardt, and B. Hamprecht, “Glycogen in astrocytes: possible function as lactate supply for neighboring cells,” Brain Research, vol. 623, no. 2, pp. 208–214, 1993. View at Publisher · View at Google Scholar · View at Scopus
  94. J. X. Wilson, “Antioxidant defense of the brain: a role for astrocytes,” Canadian Journal of Physiology and Pharmacology, vol. 75, no. 10-11, pp. 1149–1163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Järlestedt, C. I. Rousset, M. Faiz et al., “Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic-ischemic brain injury in mice,” PLoS ONE, vol. 5, no. 4, Article ID e10397, 2010. View at Publisher · View at Google Scholar · View at PubMed
  96. Y. Jin, A. J. Silverman, and S. J. Vannucci, “Mast cells are early responders after hypoxia-ischemia in immature rat brain,” Stroke, vol. 40, no. 9, pp. 3107–3112, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. M.-E. Brochu, S. Girard, K. Lavoie, and G. Sébire, “Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: an experimental study,” Journal of Neuroinflammation, vol. 20, pp. 55–69, 2011. View at Publisher · View at Google Scholar · View at PubMed
  98. Y. Huh, J. W. Jung, C. Park et al., “Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats,” Neuroscience Letters, vol. 349, no. 1, pp. 63–67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. R. V. Bhat, R. DiRocco, V. R. Marcy et al., “Increased expression of IL-1β converting enzyme in hippocampus after ischemia: selective localization in microglia,” Journal of Neuroscience, vol. 16, no. 13, pp. 4146–4154, 1996. View at Google Scholar · View at Scopus
  100. R. C. Silveira and R. S. Procianoy, “Interleukin-6 and tumour necrosis factor-a levels in plasma and cerebral spinal fluid of term newborn infants with hypoxic-ischemic encephalopathy,” Journal of Pediatrics, vol. 143, pp. 625–629, 2003. View at Google Scholar
  101. D. Davalos, J. Grutzendler, G. Yang et al., “ATP mediates rapid microglial response to local brain injury in vivo,” Nature Neuroscience, vol. 8, no. 6, pp. 752–758, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. G. Raivich, “Like cops on the beat: the active role of resting microglia,” Trends in Neurosciences, vol. 28, no. 11, pp. 571–573, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. H. Kettenmann, “Neuroscience: the brain's garbage men,” Nature, vol. 446, no. 7139, pp. 987–989, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  104. J. A. Ivacko, R. Sun, and F. S. Silverstein, “Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats,” Pediatric Research, vol. 39, no. 1, pp. 39–47, 1996. View at Google Scholar · View at Scopus
  105. A. McRae, E. Gilland, E. Bona, and H. Hagberg, “Microglia activation after neonatal hypoxic-ischemia,” Developmental Brain Research, vol. 84, no. 2, pp. 245–252, 1995. View at Publisher · View at Google Scholar · View at Scopus
  106. V. Biran, L.-M. Joly, A. Héron et al., “Glial activation in white matter following ischemia in the neonatal P7 rat brain,” Experimental Neurology, vol. 199, no. 1, pp. 103–112, 2006. View at Publisher · View at Google Scholar · View at PubMed
  107. A. Basu, J. Lazovic, J. K. Krady et al., “Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 1, pp. 17–29, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  108. A. I. Bartha, S. P. Miller, A. Foster-Barber et al., “Cytokines are associated with cerebral metabolism and outcome in term neonatal encephalopathy,” Developmental Neuroscience, vol. 27, article 270, 2005. View at Google Scholar
  109. J. A. Wixey, H. E. Reinebrant, M. L. Carty, and K. M. Buller, “Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain,” Journal of Neuroimmunology, vol. 212, no. 1-2, pp. 35–43, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  110. A. R. Amin, M. G. Attur, G. D. Thakker et al., “A novel mechanism of action of tetracyclines: effects on nitric oxide synthases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 24, pp. 14014–14019, 1996. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Yrjänheikki, R. Keinänen, M. Pellikka, T. Hökfelt, and J. Koistinaho, “Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15769–15774, 1998. View at Publisher · View at Google Scholar
  112. J. Yrjänheikki, T. Tikka, R. Keinänen, G. Goldsteins, P. H. Chan, and J. Koistinaho, “A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13496–13500, 1999. View at Publisher · View at Google Scholar
  113. R. N. Brogden, T. M. Speight, and G. S. Avery, “Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use,” Drugs, vol. 9, no. 4, pp. 251–291, 1975. View at Google Scholar · View at Scopus
  114. H. Macdonald, R. G. Kelly, and E. S. Allen, “Pharmacokinetic studies on minocycline in man,” Clinical Pharmacology and Therapeutics, vol. 14, no. 5, pp. 852–861, 1973. View at Google Scholar
  115. C. C. Leonardo, A. K. Eakin, J. M. Ajmo et al., “Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat,” Journal of Neuroinflammation, vol. 5, pp. 34–45, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  116. M. Lechpammer, S. M. Manning, F. Samonte et al., “Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia,” Neuropathology and Applied Neurobiology, vol. 34, no. 4, pp. 379–393, 2008. View at Publisher · View at Google Scholar · View at PubMed
  117. M. Ahuja, M. Bishnoi, and K. Chopra, “Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity,” Toxicology, vol. 244, no. 2-3, pp. 111–122, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  118. L. Zhang, Y. Shirayama, E. Shimizu, M. Iyo, and K. Hashimoto, “Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain,” European Journal of Pharmacology, vol. 544, no. 1–3, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  119. R. K. Zabad, L. M. Metz, T. R. Todoruk et al., “The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study,” Multiple Sclerosis, vol. 13, no. 4, pp. 517–526, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. Y. Lampl, M. Boaz, R. Gilad et al., “Minocycline treatment in acute stroke: an open-label, evaluator-blinded study,” Neurology, vol. 69, no. 14, pp. 1404–1410, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  121. M. O. Griffin, E. Fricovsky, G. Ceballos, and F. Villarreal, “Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature,” American Journal of Physiology, vol. 299, no. 3, pp. C539–C548, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  122. J. M. Plane, Y. Shen, D. E. Pleasure, and W. Deng, “Prospects for minocycline neuroprotection,” Archives of Neurology, vol. 67, no. 12, pp. 1442–1448, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  123. K. M. Buller, M. L. Carty, H. E. Reinebrant, and J. A. Wixey, “Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?” Journal of Neuroscience Research, vol. 87, no. 3, pp. 599–608, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  124. D. R. Laurence and P. N. Bennett, Eds., Clinical Pharmacology, Churchill Livingstone, New York, NY, USA, 6th edition, 1987.
  125. J. G. Hardman and L. E. Limbird, Eds., Goodman and Gilman's the Pharmacological Basis of Therapeutics, The Mcgraw-Hill Companies, New York, NY, USA, 9th edition, 1996.
  126. A. Cascio, C. Di Liberto, M. D'Angelo et al., “No findings of dental defects in children treated with minocycline,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 7, pp. 2739–2741, 2004. View at Publisher · View at Google Scholar · View at PubMed
  127. A. S. Geiger, A. C. Rice, and S. M. Shapiro, “Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats,” Neonatology, vol. 92, no. 4, pp. 219–226, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  128. S. Lin, X. Wei, K. R. Bales et al., “Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat,” European Journal of Neuroscience, vol. 22, no. 1, pp. 21–27, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. S. M. Shapiro, V. K. Bhutani, and L. Johnson, “Hyperbilirubinemia and kernicterus,” Clinics in Perinatology, vol. 33, no. 2, pp. 387–410, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. J. V. Aranda and R. Thomas, “Systematic review: intravenous ibuprofen in preterm newborns,” Seminars in Perinatology, vol. 30, no. 3, pp. 114–120, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. A. Varvarigou, C. L. Bardin, K. Beharry, S. Chemtob, A. Papageorgiou, and J. V. Aranda, “Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants,” Journal of the American Medical Association, vol. 275, no. 7, pp. 539–544, 1996. View at Publisher · View at Google Scholar · View at Scopus
  132. J. M. R. Parepally, H. Mandula, and Q. R. Smith, “Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin,” Pharmaceutical Research, vol. 23, no. 5, pp. 873–881, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  133. E. M. Park, B. P. Cho, B. T. Volpe, M. O. Cruz, T. H. Joh, and S. Cho, “Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression,” Neuroscience, vol. 132, no. 3, pp. 625–631, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  134. D. F. Antezana, R. E. Clatterbuck, N. J. Alkayed et al., “High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats,” Journal of Neurosurgery, vol. 98, no. 4, pp. 860–866, 2003. View at Google Scholar · View at Scopus
  135. P. M. Patel, J. C. Drummon, T. Sano, D. J. Cole, C. J. Kalkman, and T. L. Yaksh, “Effect of ibuprofen on regional eicosanoid production and neuronal injury after forebrain ischemia in rats,” Brain Research, vol. 614, no. 1-2, pp. 315–324, 1993. View at Google Scholar · View at Scopus
  136. D. J. Cole, P. M. Patel, L. Reynolds, J. C. Drummond, and S. Marcantonio, “Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume,” Journal of Pharmacology and Experimental Therapeutics, vol. 266, no. 3, pp. 1713–1717, 1993. View at Google Scholar · View at Scopus
  137. S. P. Miller, E. E. Mayer, R. I. Clyman, D. V. Glidden, S. E. G. Hamrick, and A. J. Barkovich, “Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks' gestation at birth,” Pediatrics, vol. 117, no. 5, pp. 1626–1631, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  138. H. Aly, L. Abd-Rabboh, M. El-Dib et al., “Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial,” Journal of Perinatology, vol. 29, no. 6, pp. 438–443, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. G. P. Lim, F. Yang, T. Chu et al., “Ibuprofen suppresses plaque pathology and inflammation in a mouse model for alzheimer's disease,” Journal of Neuroscience, vol. 20, no. 15, pp. 5709–5714, 2000. View at Google Scholar · View at Scopus
  140. C. Yokota, T. Kaji, Y. Kuge, H. Inoue, N. Tamaki, and K. Minematsu, “Temporal and topographic profiles of cyclooxygenase-2 expression during 24 h of focal brain ischemia in rats,” Neuroscience Letters, vol. 357, no. 3, pp. 219–222, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. E. Candelario-Jalil and B. L. Fiebich, “Cyclooxygenase inhibition in ischemic brain injury,” Current Pharmaceutical Design, vol. 14, no. 14, pp. 1401–1418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. N. Fathali, R. P. Ostrowski, T. Lekic et al., “Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury,” Critical Care Medicine, vol. 38, no. 2, pp. 572–578, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  143. M. L. Carty, J. A. Wixey, H. E. Reinebrant, G. Gobe, P. B. Colditz, and K. M. Buller, “Ibuprofen inhibits neuroinflammation and attenuates white matter damage following hypoxia-ischemia in the immature rodent brain,” Brain Research, vol. 1402, pp. 9–19, 2011. View at Publisher · View at Google Scholar · View at PubMed
  144. E. Taskin, K. Ozcan, N. Canacankatan, M. Satar, H. Yapıcıoğlu, and Ş. Erdoğan, “The effects of indomethacin on caspases, glutathione level and lipid peroxidation in the newborn rats with hypoxic-ischemic cerebral injury,” Brain Research, vol. 1289, pp. 118–123, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  145. E. Tutak, M. Satar, S. Zorludemir, Ş. Erdoğan, H. Yapıcıoğlu, and N. Narlı, “Neuroprotective effects of indomethacin and aminoguanidine in the newborn rats with hypoxic-ischemic cerebral injury,” Neurochemical Research, vol. 30, no. 8, pp. 937–942, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  146. Y. Cheng, M. Deshmukh, A. D'Costa et al., “Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury,” Journal of Clinical Investigation, vol. 101, no. 9, pp. 1992–1999, 1998. View at Google Scholar · View at Scopus
  147. M. Dihné, C. Grommes, M. Lutzenburg, O. W. Witte, and F. Block, “Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats,” Stroke, vol. 33, no. 12, pp. 3006–3011, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. T. Tokuno, K. Kataoka, T. Asai et al., “Functional changes in thalamic relay neurons after focal cerebral infarct: a study of unit recordings from VPL neurons after MCA occlusion in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 12, no. 6, pp. 954–961, 1992. View at Google Scholar · View at Scopus
  149. R. B. Banati, A. Cagnin, D. J. Brooks et al., “Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury,” Neuroreport, vol. 12, no. 16, pp. 3439–3442, 2001. View at Google Scholar · View at Scopus
  150. B. P. Cho, D. Y. Song, S. Sugama et al., “Pathological dynamics of activated microglia following medial forebrain bundle transection,” GLIA, vol. 53, no. 1, pp. 92–102, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  151. F. Block, M. Dihné, and M. Loos, “Inflammation in areas of remote changes following focal brain lesion,” Progress in Neurobiology, vol. 75, no. 5, pp. 342–365, 2005. View at Publisher · View at Google Scholar · View at PubMed
  152. N. Marlow, A. S. Rose, C. E. Rands, and E. S. Draper, “Neuropyschological and educational problems at school age associated with neonatal encephalopathy,” Archives of Disease in Childhood, vol. 90, pp. 380–387, 2005. View at Google Scholar
  153. D. S. Paterson, R. A. Belliveau, F. Trachtenberg, and H. C. Kinney, “Differential development of 5-HT receptor and the serotonin transporter binding in the human infant medulla,” Journal of Comparative Neurology, vol. 472, no. 2, pp. 221–231, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  154. D. S. Paterson, F. L. Trachtenberg, E. G. Thompson et al., “Multiple serotonergic brainstem abnormalities in sudden infant death syndrome,” Journal of the American Medical Association, vol. 296, no. 17, pp. 2124–2132, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  155. H. C. Kinney, G. B. Richerson, S. M. Dymecki, R. A. Darnall, and E. E. Nattie, “The brainstem and serotonin in the sudden infant death syndrome,” Annual Review of Pathology: Mechanisms of Disease, vol. 4, pp. 517–550, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  156. M. H. Malloy and H. J. Hoffman, “Prematurity, sudden infant death syndrome, and age of death,” Pediatrics, vol. 96, no. 3, pp. 464–471, 1995. View at Google Scholar · View at Scopus
  157. F. I. Tarazi, E. C. Tomasini, and R. J. Baldessarini, “Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi,” Neuroscience Letters, vol. 254, no. 1, pp. 21–24, 1998. View at Publisher · View at Google Scholar · View at Scopus
  158. G. H. Moll, C. Mehnert, M. Wicker et al., “Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood,” Developmental Brain Research, vol. 119, no. 2, pp. 251–257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  159. L. Galineau, E. Kodas, D. Guilloteau, M. P. Vilar, and S. Chalon, “Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study,” Neuroscience Letters, vol. 363, no. 3, pp. 266–271, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  160. F. C. Zhou, E. C. Azmitia, and S. Bledsoe, “Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus,” Developmental Brain Research, vol. 84, no. 1, pp. 89–98, 1995. View at Publisher · View at Google Scholar · View at Scopus
  161. D. M. Inman and O. Steward, “Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice,” Journal of Comparative Neurology, vol. 462, no. 4, pp. 431–449, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  162. A. L. Hawthorne, H. Hu, B. Kundu et al., “The unusual response of serotonergic neurons after CNS injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar,” Journal of Neuroscience, vol. 31, no. 15, pp. 5605–5616, 2011. View at Publisher · View at Google Scholar · View at PubMed
  163. G. Guo and N. R. Bhat, “p38α MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline's neuroprotective action,” Neurochemical Research, vol. 32, no. 12, pp. 2160–2166, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  164. L. W. Fan, S. Lin, Y. Pang, P. G. Rhodes, and Z. Cai, “Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat,” European Journal of Neuroscience, vol. 24, no. 2, pp. 341–350, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  165. N. Matsukawa, T. Yasuhara, K. Hara et al., “Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke,” BMC Neuroscience, vol. 10, article 1471, p. 126, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus